Morgan Stanley Opgen Inc Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $62.0 $841 - $434,620	7,010 New	7,010 $0
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.79 $438 - $1,082	-1,370 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$0.72 - $1.11 $986 - $1,520	1,370 New	1,370 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.0 - $2.94 $5,647 - $16,602	-5,647 Reduced 80.48%	1,370 $1,000
Q3 2021 Nov 15, 2021	BUY	$2.18 - $3.58 $15,297 - $25,120	7,017 New	7,017 $20,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.